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Blood lead and chronic kidney disease in the general United nonoccupational exposure to lead and a higher incidence
States population: Results from NHANES III. of nephropathy [2–6]. However, these studies involved
Background. High lead exposure is associated with hyper- relatively small numbers of patients. More recently,tension and renal dysfunction but the effect of low-level envi-
large-scale epidemiologic studies have noted associationsronmental exposure is not as well studied.
between environmental exposure to lead, even at lowMethods. We examined the association between blood lead
and renal function among a representative sample of the civil- levels, and higher serum creatinine [7–9]. However, none
ian noninstitutionalized United States population with and of these studies have been conducted among a represen-
without hypertension, age 20 years old or older, participating in tative sample of the general United States population.the Third National Health and Nutrition Examination Survey
Although exact estimates vary, the prevalence of chronic(NHANES III) (N  15,211). Elevated serum creatinine was
kidney disease (CKD) in the general United States popu-defined as99th percentile of each race-sex specific distribution
for healthy young adults and chronic kidney disease (CKD) as lation is high [10, 11]. In additional, renal insufficiency,
a glomerular filtration rate (GFR) 60 mL/min estimated using even prior to end-stage renal disease (ESRD), is associated
the Modification of Diet in Renal Disease (MDRD) formula. with several comorbidities, including anemia [12] and anResults. Among persons with and without hypertension, mean
elevated risk of cardiovascular disease [13]. Despite ablood lead was 4.21 and 3.30 ug/dL, respectively, the prevalence
high prevalence and concomitant risk of disease, the eti-of elevated serum creatinine was 11.5% and 1.8%, respectively,
and CKD was 10.0% and 1.1%, respectively. Among persons with ologies of CKD have remained elusive [14, 15]. We exam-
hypertension, a graded association was present between higher ined the association between exposure to lead and CKD
quartile of blood lead and a higher odds ratio of both an ele- among the United States population using data from thevated serum creatinine and CKD. Comparing the highest to
Third National Health and Nutrition Examination Sur-lowest quartile of blood lead, the multivariate adjusted odds
vey (NHANES III).ratio (95% CI) of an elevated serum creatinine and CKD were
2.41 (1.46, 3.97) and 2.60 (1.52, 4.45), respectively. The analo-
gous adjusted odds ratios (95% CI) among normotensives were
METHODS1.09 (0.53, 2.22) and 1.09 (0.41, 2.89), respectively. Associations
were consistent when modeling lead as a continuous variable NHANES III was conducted from 1988 through 1994
and in all subgroups except smokers.
by the National Center for Health statistics [16]. NHANESConclusion. In the United States population with hyper-
III consisted of a standardized questionnaire adminis-tension, exposure to lead, even at low levels, is associated with
CKD. Reduction of lead exposure may reduce the burden of tered in the home by a trained interviewer followed by
CKD in the community. a detailed physical examination at a Mobile Examination
Center (MEC). Participants were selected via a complex
sampling methodology with non-Hispanic African Ameri-
The nephrotoxic effects of lead were first noted over cans, Mexican Americans, the elderly, and children delib-
a century ago [1]. Since then, many studies have identi- erately over-sampled to achieve stable subpopulation
fied a strong association between both occupational and estimates. Overall, 18,825 adults, 20 years of age or older,
participated in NHANES III.
Data collected at the home interview relevant to the
Key words: chronic kidney disease, lead exposure, hypertension. current analysis included self-report of demographics
(age, race, and gender), education level attained, ciga-Received for publication August 19, 2002
Accepted for publication October 11, 2002 rette smoking, household income, a history of diabetes,
and blood pressure medication usage. Three blood pres- 2003 by the International Society of Nephrology
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sure measurements were taken in the home and three a strong graded association was present between higher
at the MEC by a trained and certified observer following blood lead levels and a higher prevalence of elevated
the NHANES III study protocol. The average of all avail- serum creatinine and CKD. However, the effect of blood
able blood pressure measurements were used for data lead on elevated creatinine, estimated GFR, and CKD
analysis. Hypertension was defined as systolic blood was different for persons with and without hypertension
pressure 140 mmHg and/or diastolic blood pressure (all P interaction  0.001). Therefore, calculations were
90 mmHg and/or current use of antihypertensive medi- performed separately for persons with and without hy-
cations. pertension. Demographic distributions, mean levels of
Serum was collected at the MEC and creatinine levels blood lead, serum creatinine, and estimated GFR were
were measured by the modified kinetic Jaffe reaction determined for the study population. A quantile regres-
using a Hitachi 737 analyzer (Boehringer Mannheim sion model, including fifth-order polynomials of esti-
Corporation, Indianapolis, IN, USA) [17] and blood lead mated GFR and age, was used to determine the associa-
levels were determined using graphite furnace atomic tion of median (50th percentile) blood lead with estimated
absorption spetrophotometry. Two levels of quality con- GFR. Blood lead levels were divided into quartiles and
trol pools were used to ensure accurate blood lead mea- the prevalence of elevated serum creatinine and CKD
surement. The levels were chosen to reflect “low-nor- were determined. Next, the age, race and gender adjusted
mal” (5 g/dL) and “high-normal” blood lead level odds ratios of elevated serum creatinine and CKD were
(20g/dL). The coefficient of variation was under 10% calculated by blood lead quartile and trends in the odds
for each of seven samples with a mean lead level ranging ratios across blood lead quartiles were assessed using
from 4.86 to 53.5 g/dL. the chi-squared test for trend. Odds ratios and trends
were also computed after additional adjustment for sys-Outcome definition
tolic blood pressure, diabetes, household income, educa-
Two outcome measures were used in the current analy- tion level, health insurance, cigarette smoking, alcohol
sis: elevated serum creatinine and CKD. Because it has consumption, body mass index, and history of cardiovas-
been reported that non-Hispanic African Americans may cular disease.
have a higher serum creatinine level at the same GFR Associations using continuous blood lead levels were
as non-Hispanic Caucasians, we defined elevated serum determined for all persons with and without hyperten-
creatinine using race-gender specific cut points of 1.5
sion and after further stratification by race-ethnicity (non-mg/dL and 1.3 mg/dL for non-Hispanic Caucasian men
Hispanic Caucasians, non-Hispanic African Americans,and women; 1.6 and 1.4 mg/dL for non-Hispanic Afri-
and Mexican Americans), gender, current cigarette smok-can American men and women; and1.4 and 1.2 mg/dL
ing, diabetes mellitus (fasting blood glucose126 mg/dL)for Mexican American men and women, respectively.
and household income ($20,000 and$20,000). Differ-These cut points correspond to the 99th percentiles of the
ences across subgroups were assessed using tests for in-race-gender specific serum creatinine distributions for
teraction. Due to its skewed distribution, blood lead washealthy young men and women (age, 20 to 39 years old
log transformed for the continuous analyses. Odds ratioswithout diabetes mellitus or hypertension) in this study.
are quoted for a twofold higher blood lead.GFR was estimated by adjusting serum creatinine for
The survey weights provided in the NHANES III dataage, race, and sex using a formula proposed and validated
set were applied in all analyses to obtain United Statesby the Modification of Diet in Renal Disease (MDRD)
population estimates. The svy commands in Stata 6.0research group. [18] Specifically, GFR was estimated
were used to account for the complex survey design ofusing the following formula:
NHANES III and obtain proper standard errors for all
Estimated GFR (mL/min/1.73 m2)  exp (5.228 estimates [21].
 1.154 * ln (creatinine)  0.299 (if female)
RESULTS 0.192 (if African American)  0.203 * ln (age))
On average, compared to persons without hyperten-Furthermore, serum creatinine was adjusted for dif-
sion, persons with hypertension were older (Table 1). Inferences in calibration between the NHANES and MDRD
additional, a higher percentage of persons with hyperten-laboratories as described previously [19]. CKD was de-
sion were non-Hispanic African Americans and a lowerfined as a GFR60 mL/min/1.73 m2, the standard defini-
percentage were Mexican-Americans (Table 1). Meantion of CKD, as defined in the most recent Kidney Dis-
blood lead and serum creatinine were higher and esti-ease Outcome Quality Initiative (KDOQI) guidelines [20].
mated GFR was lower for persons with hypertension.
Statistical methods Additionally, a greater proportion of participants with
hypertension had an elevated serum creatinine and CKDInitial analyses were performed for persons with and
without hypertension pooled together. In these analyses, compared to persons without hypertension.
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Table 1. Demographic characteristics of the study populationa
Hypertension Normotension
(N  4813) (N  10,398) P value
Age grouping %
20–39 11.1 56.1
40–59 32.9 31.4
60–74 36.4 10.0
75 17.6 2.5 0.001
Non-Hispanic African
American % 13.5 10.5 0.001
Mexican American % 3.4 6.2 0.001
Male % 47.5 48.0 0.76
Blood lead lg/dL 4.21 (0.14) 3.30 (0.10) 0.001
Serum creatinine mg/dL 1.14 (0.01) 1.05 (0.004) 0.001
Estimated glomerular
filtration rate mL/min 95 (0.7) 115 (0.7) 0.001
Elevated serum
creatinineb % 11.5 1.8 0.001
Chronic kidney disease % 10.0 1.1 0.001
a Percentage or mean (standard deviation)
b Serum creatinine 1.5 and 1.3 mg/dL for non-Hispanic Caucasian men and
women, 1.6 and 1.4 for non-Hispanic African American men and women, and
1.4 and 1.2 for Mexican American men and women
After age adjustment, among persons with hyperten-
sion, higher blood lead level was associated with a lower
estimated GFR (Fig. 1A). This relationship was present
throughout the entire range of GFR among non-Hispanic
African Americans and Mexican Americans and was pres-
ent for non-Hispanic Caucasians with an estimated GFR
60 mL/min/1.73m2 (data not shown). The decrease in
estimated GFR associated with higher blood lead was
much less steep among persons without hypertension
(Fig. 1B).
The prevalence of elevated serum creatinine and CKD
were higher at higher blood lead quartiles among persons
with and without hypertension (Table 2). Among partici-
pants with hypertension, a graded association was pres-
ent between higher blood lead quartiles and a higher
prevalence of elevated serum creatinine and CKD after
adjustment for age, race, and gender (demographic ad-
justment) and further adjustment for diabetes, systolic
blood pressure, household income, education level, health
care coverage, and cigarette smoking (full adjustment). Fig. 1. Median (solid line) estimated glomerular filtration rate (GFR)
with 95% CI (dash lines) by blood lead level among the United StatesAfter full adjustment, the odds ratio (95% CI) of ele-
population with hypertension (A) and without hypertension (B) ad-vated serum creatinine and CKD in the highest com-
justed to 60 years of age.
pared to lowest quartile were 2.41 (1.46, 3.97) and 2.60
(1.52, 4.45), respectively. In contrast, after adjustment for
age, race, and gender, no association was present be-
tween blood lead quartile and prevalence of elevated elevated serum creatinine and CKD associated with two-
fold higher blood lead level were 1.07 (0.81, 1.41) andserum creatinine or CKD among persons without hyper-
tension. Further adjustment did not alter this finding. 1.04 (0.72, 1.50), respectively.
For persons with hypertension, the association be-Among persons with hypertension, each twofold higher
blood lead level was associated with an adjusted odds tween higher blood lead and an increased prevalence of
elevated serum creatinine and CKD was present amongratio of elevated serum creatinine and CKD (95% CI) of
1.43 (1.20, 1.71) and 1.38 (1.15, 1.66), respectively (Ta- all subgroups except persons who currently smoked ciga-
rettes (Table 3). For non-Hispanic African Americans,ble 3). In contrast, among persons without hypertension,
no association was present; the odds ratios (95% CI) of higher blood lead levels were associated with CKD [odds
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Table 2. Prevalence and odds ratios (95% CI) of chronic kidney disease by blood lead quartile and hypertension status,
among 13,141 NHANES III participants
Hypertension
Elevated serum creatinine Chronic kidney disease
Blood lead Odds ratioa Adjusted odds Odds ratioa Adjusted odds
(range, g/dL) % (95% CI) ratiob (95% CI) % (95% CI) ratiob (95% CI)
Quartile 1 (0.7 to 2.4) 7.2 1.00 1.00 6.1 1.00 1.00
Quartile 2 (2.5 to 3.8) 12.1 1.56 (1.04, 2.35) 1.47 (1.03, 2.10) 10.4 1.56 (1.02, 2.38) 1.44 (1.00, 2.09)
Quartile 3 (3.9 to 5.9) 12.4 1.68 (1.24, 2.26) 1.80 (1.34, 2.42) 10.8 1.69 (1.21, 2.33) 1.85 (1.32, 2.59)
Quartile 4 (6.0 to 56.0) 16.3 2.07 (1.26, 3.40) 2.41 (1.46, 3.97) 14.1 2.27 (1.31, 3.91) 2.60 (1.52, 4.45)
P trend 0.001 0.01 0.001 0.001 0.001 0.001
Normotension
Elevated serum creatinine Chronic kidney disease
Blood lead Odds ratioa Adjusted odds Odds ratioa Adjusted odds
(range, g/dL) % (95% CI) ratiob (95% CI) % (95% CI) ratiob (95% CI)
Quartile 1 (0.7 to 1.6) 1.1 1.00 1.00 0.4 1.00 1.00
Quartile 2 (1.7 to 2.8) 1.6 0.92 (0.48, 1.75) 1.11 (0.56, 2.21) 0.8 0.84 (0.35, 2.01) 0.90 (0.37, 2.16)
Quartile 3 (2.9 to 4.6) 2.2 1.04 (0.56, 1.94) 1.19 (0.62, 2.25) 1.3 1.03 (0.45, 2.33) 1.00 (0.45, 2.22)
Quartile 4 (4.7 to 52.9) 2.6 0.92 (0.50, 1.72) 1.09 (0.53, 2.22) 2.1 1.18 (0.50, 2.71) 1.09 (0.41, 2.89)
P trend 0.26 0.79 0.76 0.02 0.30 0.36
a Adjusted for age, race, and gender
b Adjustment for age, gender, systolic blood pressure, diabetes mellitus, current cigarette smoking, history of cardiovascular disease (myocardial infarction, stroke,
congestive heart failure), body mass index, alcohol consumption, household income, marital status, and health insurance
ratio (OR)  1.39; 95% CI, 1.10, 1.75], however, the The marked differences in the association between
blood lead levels and elevated creatinine and CKD forassociation was not statistically significant for elevated
persons with and without hypertension were not unex-serum creatinine (OR 1.21; 95% CI, 0.96, 1.52). A sig-
pected. Lead poisoning is a known cause of both hyper-nificant interaction was present between cigarette smok-
tension and renal impairment and higher levels of leading and blood lead; blood lead was associated with an
exposure may cause both hypertension and renal insuf-increased risk of CKD among nonsmokers but not smok-
ficiency. However, not all previous studies found associa-ers (P interaction  0.007 and 0.03 for elevated serum
tions between blood lead and blood pressure and there-creatinine and CKD, respectively). Among the popula-
fore may not have explored the possible interaction oftion without hypertension, elevated serum creatinine and
blood pressure, blood lead, and renal function [22, 23].CKD were not associated with blood lead for any sub-
Given the high prevalence of hypertension among per-groups except for persons with diabetes where higher
sons with CKD, the interaction of hypertension, bloodblood lead was associated with a higher prevalence of
lead, and CKD warrants further investigation in a pro-CKD but not elevated serum creatinine.
spective cohort [11].
Occupational exposure to lead first occurred in ap-
DISCUSSION proximately 2500 bc and the first reports of the toxic
The results of the current analysis indicate that blood effects of such exposure were noted in 200 bc. However,
lead, even at low levels, is associated with an elevated the first report of the clinical nephrotoxicity of lead expo-
serum creatinine and CKD among persons with hyper- sure was by Lancereaux in 1862. During the late nine-
tension in the general United States population. These teenth and early twentieth century a large number of
associations were strong, dose-dependent and consistent reports on the association between high occupational
before and after comprehensive adjustment. These asso- exposure to lead and nephritis were reported. The fre-
ciations were present when evaluating blood lead as a quency of occupational exposure to lead during this time
continuous and categorical variable and evaluating renal made lead nephropathy a common diagnosis. The neph-
function using elevated creatinine and estimated GFR rotoxic effects of lead exposure were not limited to case
(i.e., CKD). In contrast, no association was present be- reports. In the first half of the twentieth century several
tween blood lead and either elevated serum creatinine epidemiologic mortality studies found increased renal
or CKD among persons without hypertension. This was disease mortality among occupational cohorts with high
apparent for the overall population without hyperten- lead exposures. Although there has been much debate
sion and within all subgroups except persons with dia- over the past 20 years regarding the relationship between
lead exposure and chronic renal failure, several studiesbetes.
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Table 3. Adjusteda odds ratios (95% CI) of chronic kidney disease sons with a broad range of renal function and using cate-
associated with a twofold higher blood lead level
gorical outcomes should limit the misclassification of re-for the overall population and by subgroup
nal function based on day-to-day variation in serum
Hypertension creatinine [27]. In additional, the results were consistent
Elevated creatinine Chronic kidney disease when assessing renal insufficiency as estimated GFR us-
Overall 1.43 (1.20, 1.72) 1.38 (1.15, 1.66) ing a validated formula from the MDRD study. Finally,
Non-Hispanic exposure to lead was assessed by blood lead. Although
Caucasians 1.49 (1.22, 1.83) 1.46 (1.19, 1.79)
there are better measurements of long-term environmen-Non-Hispanic
African Americans 1.21 (0.96, 1.52) 1.39 (1.10, 1.75) tal lead exposure in individuals, the feasibility of their
Mexican Americans 2.13 (1.46, 3.11) 2.18 (1.48, 3.22) use was prohibitive given the large scale and broad scope
Males 1.71 (1.38, 2.12) 1.66 (1.31, 2.10)
of NHANES III [28, 29]. Blood lead is the most com-Females 1.32 (1.06, 1.64) 1.38 (1.10, 1.75)
Nonsmokers 1.50 (1.24, 1.80) 1.53 (1.27, 1.86) monly used measure of environmental lead exposure in
Smokers 1.04 (0.70, 1.54) 0.88 (0.60, 1.30) population studies and the results of the current analysis
No diabetes 1.42 (1.15, 1.75) 1.43 (1.14, 1.79)
still provide strong data on the association between expo-Diabetes 1.38 (1.00, 1.91) 1.44 (1.01, 2.05)
Income $20,000 1.39 (1.11, 1.74) 1.42 (1.12, 1.78) sure to lead and renal function. Furthermore, large popu-
Income $20,000 1.61 (1.27, 2.03) 1.60 (1.23, 2.10) lation studies indicate there exists a high correlation be-
No hypertension tween blood lead measurement and total body burden
Elevated creatinine Chronic kidney disease of lead as determined by the ethylenediaminetetraacetic
acid (EDTA)-lead mobilization test or x-ray fluores-Overall 1.07 (0.81, 1.41) 1.04 (0.72, 1.38)
Non-Hispanic cence [4, 30].
Caucasians 1.08 (0.76, 1.54) 1.09 (0.69, 1.73) Results from the majority of studies suggest that higher
Non-Hispanic
blood lead levels are the cause, rather than the result, ofAfrican Americans 1.05 (0.73, 1.52) 1.57 (0.68, 3.62)
Mexican Americans 0.85 (0.39, 1.86) 1.23 (0.40, 3.75) lower renal function [3–5, 31]. For example, in an Austra-
Males 1.06 (0.69, 1.65) 1.32 (0.80, 1.34) lian study among individuals with no reported history of
Females 1.01 (0.74, 1.39) 0.81 (0.49, 1.34)
heavy lead exposure, there were no differences in bloodNonsmokers 1.09 (0.81, 1.46) 1.13 (0.72, 1.76)
Smokers 0.91 (0.52, 1.60) 0.85 (0.43, 1.68) lead levels in those with normal renal function, or mild
No diabetes 1.07 (0.79, 1.45) 1.06 (0.69, 1.65) or severe renal dysfunction. In contrast, blood lead con-
Diabetes 1.26 (0.59, 2.68) 2.82 (1.05, 7.59)
centrations were higher among adults with renal failureIncome $20,000 0.93 (0.67, 1.30) 0.89 (0.63, 1.26)
Income $20,000 1.13 (0.77, 1.66) 1.31 (0.71, 2.41) and a history of childhood lead poisoning [31]. Other
a Adjustment for age, gender, systolic blood pressure, diabetes mellitus, current studies provide data that support the hypothesis that
cigarette smoking, history of cardiovascular disease (myocardial infarction, renal function does not alter blood lead levels [3, 32].stroke, congestive heart failure), body mass index, alcohol consumption, house-
hold income, marital status, and health insurance The less steep decrease in GFR associated with higher
blood lead in persons without hypertension (Fig. 1B)
further confirms the premise that renal function per se
does not cause increased blood lead level.
have found a higher incidence of ESRD among persons Although previous studies have investigated the asso-
with high levels of lead exposure. Recent epidemiologic ciation between lead exposure and renal function prior
studies have expanded the exploration for clues into the to ESRD, there are several aspects of the current study
relationship between lead and renal failure to study the that make it unique. The current analysis provides data
effects of low-level environmental lead exposure and that is representative of the general noninstitutionalized
renal insufficiency, prior to ESRD. Studies, both cross- United States population. Most previous studies of lead
sectional and cohort studies, performed over the past 25 exposure have focused on groups with high-exposure
years have found associations between elevated blood levels. While the Normative Aging Study evaluated the
lead levels and reduced renal function. effect of low levels of blood lead and renal function in
Although the overall results of the current study are the United States population, this study was limited to
generally consistent with previous studies, some limita- men, 97% of whom were Caucasian, and consisted of a
tions in the methodology we applied deserve mention. smaller sample size (N  744) compared to the current
First, NHANES III is a cross-sectional survey. The lack study (N 15,211) [33]. Although data from NHANES II
of prospective follow-up limits the ability to make infer- was used to study the association between blood lead
ences regarding the causality of the associations detected and blood pressure, no interaction between blood lead,
[24]. Second, serum creatinine is a relatively crude mea- blood pressure, and kidney function was found [34]. Fi-
sure of renal function [25, 26]. Due to substantial intra- nally, investigators from the Cadmibel Study found an
personal variability associated with serum creatinine, association between blood lead and renal function in
analyses relied upon categorical outcomes (i.e., elevated the general population of Belgium [8]. In contrast, no
association was present between blood lead and bloodcreatinine and CKD). The current study included per-
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7. Lin JL, Tan DT, Hsu KH, Yu CC: Environmental lead expo-pressure in that study, and the presence of an interaction
sure and progressive renal insufficiency. Arch Intern Med 161:264–between blood lead, blood pressure, and kidney function 271, 2001
was not reported [23]. 8. Staessen JA, Lauwerys RR, Buchet JP, et al: Impairment of
renal function with increasing blood lead concentrations in theAn additional strength of the current analysis is that
general population. The Cadmibel Study Group. N Engl J Medseveral potential confounders were collected as part of
327:151–156, 1992
NHANES III for which we were able to adjust. The com- 9. Kim R, Hu H, Rotnitzky A, et al: Longitudinal relationship be-
prehensive nature of data collection in NHANES III tween dentin lead levels in childhood and bone lead levels in young
adulthood. Arch Environ Health 51:375–382, 1996enabled us to determine the independent nature of the
10. Jones CA, McQuillan GM, Kusek JW, et al: Serum creatinineassociation between blood lead and renal function. Also, levels in the US population: Third National Health and Nutrition
the broad number of covariates collected in NHANES Examination Survey. Am J Kidney Dis 32:992–999, 1998
11. Coresh J, Wei GL, McQuillan G, et al: Prevalence of high bloodIII allowed us to estimate GFR using the abbreviated
pressure and elevated serum creatinine level in the United States:MDRD formula. This method of estimating GFR has
Findings from the third National Health and Nutrition Examina-
been validated and the serum creatinine in NHANES tion Survey (1988–1994). Arch Intern Med 161:1207–1216, 2001
III was calibrated specifically for use of this formula [19]. 12. Astor BC, Muntner P, Levin A, et al: Association of kidney func-
tion with anemia: The Third National Health and Nutrition Examina-The consistency of the relationships detected using both
tion Survey (1988–1994). Arch Intern Med 162:1401–1408, 2002elevated creatinine and low GFR as outcomes, even after
13. Muntner P, He J, Hamm L, et al: Renal insufficiency and subse-
adjustment for several confounders, provides confidence quent death resulting from cardiovascular disease in the United
States. J Am Soc Nephrol 13:745–753, 2002in the results of the current study. Finally, because little
14. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of car-is known about the causes of renal insufficiency, the
diovascular disease in chronic renal disease. Am J Kidney Dis 32:current study provides important data that can be used S112–S119, 1998
in designing future studies of renal disease. 15. Perneger TV, Brancati FL, Whelton PK, Klag MJ: Studying
the causes of kidney disease in humans: A review of methodologicSince NHANES II, the blood lead concentrations have
obstacles and possible solutions. Am J Kidney Dis 25:722–731, 1995declined dramatically in the United States population
16. National Center for Health Statistics: Plan and operation of
[35–37]. For example, among the United States popula- the Third National Health and Nutrition Examination Survey,
tion aged 1 to 74 years, mean blood lead concentrations 1988–1994, Washington, DC, United States Department of Health
and Human Services Publication 1:94–1308, 1994dropped by 78% from 12.8 during NHANES II (1976
17. Kasiske B, Keane W: Laboratory assessment of renal disease:to 1980) to 2.8 during the first phase of NHANES III Clearance, urinalysis, and renal biopsy, in The Kidney, 6th edition,
(1988 to1991). However, our results indicate that even edited by Brenner B, Rector F, 2000, pp 1137–1174
18. Levey AS, Bosch JP, Lewis JB, et al: A more accurate methodthe low levels of lead that people are still exposed may
to estimate glomerular filtration rate from serum creatinine: Anot be without detrimental health effects. The decline
new prediction equation. Modification of Diet in Renal Diseasein environmental exposure to lead has been reported to Study Group. Ann Intern Med 130:461–470, 1999
be primarily the result of removal of lead from gasoline 19. Coresh J, Astor BC, McQuillan G, et al: Calibration and random
variation of the serum creatinine assay as critical elements of usingand soldered cans. Although the cross-sectional nature
equations to estimate glomerular filtration rate. Am J Kidney Disof the current study limits the inferences that can be
39:920–929, 2002
made based on the current results, given the potential 20. KDOQI Working Group: Definition and classification of stages
benefits of lead removal, reducing environmental lead of chronic kidney disease. Am J Kidney Dis 39:S46–S75, 2002
21. StataCorp: STATA Statistical Software. Release 6.0, STATA Cor-exposure may provide substantial benefits in reducing
poration, College Station, TX, 1999the burden of hypertension and CKD. 22. Staessen JA, Bulpitt CJ, Fagard R, et al: Hypertension caused
by low-level lead exposure: Myth or fact? J Cardiovasc Risk 1:87–Reprint requests to Paul Muntner, Ph.D., Department of Epidemiol-
97, 1994ogy, Tulane University SPHTM, 1430 Tulane Avenue, SL-18, New
23. Staessen JA, Roels H, Fagard R: Lead exposure and conven-Orleans, LA 70112, USA.
tional and ambulatory blood pressure: A prospective populationE-mail: pmuntner@tulane.edu
study. PheeCad Investigators. JAMA 275:1563–1570, 1996
24. Hill AB: The environment and disease: Association or causation?
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